MedTrace Logo

Randomized Controlled Trial Testing a Training Program About Section 504 of the Rehabilitation Act

NCT07710300 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-07-17

No results posted yet for this study

Summary

The goal of this training program is to learn if the intervention (i.e., training program) can improve access to Section 504 among students with disabilities and family caregivers. If students with disabilities and/or family caregivers are educated and empowered about Section 504, then there may be improved access to higher-quality of Section 504 plans. We aim to answer the following question: Is the training program effective?

If there is a comparison group: We (our research team) will compare the intervention group to a waitlist-control group to discern differences in advocacy, empowerment, and knowledge and, subsequently, higher quality Section 504 plans and greater access to services.

Participants will:

* Attend an online class for an hour and a half each week for 6 weeks
* Complete a pre-survey
* Complete a formative evaluation after each program session
* Complete a summative evaluation after the entire advocacy program
* Complete a post-survey after completing the advocacy program
* Complete a follow-up survey
* Submit a copy of their child's (or their) Section 504 plan after providing consent

Conditions

  • Students With Disabilities and/or Family Members With Students With Disabilities That Have a Section 504 Plan

Interventions

OTHER

Treatment

Training program about Section 504 for individuals with disabilities and/or family caregivers of an individual with disabilities.

OTHER

Materials-only control condition

Materials-only then access to advocacy training around Section 504 plans for individuals with disabilities and/or family caregivers of individuals with disabilities. Will have advocacy training 6 months after the control group.

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2028-09-01
Completion
2028-09-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07710300 on ClinicalTrials.gov